tiprankstipranks
Trending News
More News >
Inmune Bio Inc (INMB)
NASDAQ:INMB

Compare Inmune Bio (INMB) vs. Competitors

Compare
874 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Inmune Bio
$1.53
$42.27M
-0.74
-82.75%
1 Buy
1 Hold
0 Sell
Moderate Buy
Veru
$2.53
$40.61M
-1.98
-56.42%
1 Buy
0 Hold
0 Sell
Moderate Buy
Karyopharm Therapeutics
$6.52
$119.38M
-0.45
-34.54%
4 Buy
0 Hold
0 Sell
Strong Buy
Cue Biopharma
$0.34
$30.55M
-0.73
-75.44%
Celularity
$1.25
$35.18M
-0.37
-44.80%
Jupiter Neurosciences, Inc.
$0.53
$18.17M
-2.32
-52.95%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
INMB
Inmune Bio
1.59
-8.17
-83.71%
VERU
Veru
2.53
-3.43
-57.55%
KPTI
Karyopharm Therapeutics
6.52
-2.81
-30.13%
CUE
Cue Biopharma
0.33
-1.08
-76.31%
CELU
Celularity
1.22
-0.80
-39.60%
JUNS
Jupiter Neurosciences, Inc.
0.53
-0.44
-45.67%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts